Companies /Healthcare
Alector Inc
NASDAQ: ALEC Biotechnology
$2.10
▲ $0.27 (+14.75%) today
Markets closed · 8:01pm ET

Alector (ALEC) Earnings History & Trends

EPS and revenue vs. Street estimates · SEC filings
100%
EPS beat rate
+28.53%
Avg. EPS surprise
Consecutive EPS beats
ALEC vs Market · 30-day return after each reportALECS&P 500
−20%0%+20%+40%−25.9%−4.4%Q4 24+39.3%+6.6%Q1 25+32.1%+2.4%Q2 25+1.6%+2.5%Q3 25−21.1%−8.3%Q4 25−27.6%−1.7%Q1 26+35.0%−0.3%Q2 26
−20%0%+20%+40%Q4 24Q2 25Q4 25Q2 26
ALEC EPS Trend · estimate vs actualEstimateActual
$-0.60$-0.40$-0.20$0.00$-0.54$-0.02Q4 24$-0.46$-0.41Q1 25$-0.47$-0.30Q2 25$-0.41$-0.34Q3 25$-0.36$-0.34Q4 25$-0.28$-0.21Q1 26$-0.23$-0.21Q2 26
$-0.60$-0.40$-0.20$0.00Q4 24Q2 25Q4 25Q2 26
ALEC Revenue Trend · estimate vs actualEstimateActual
$0$20.0M$40.0M$20.4M$54.2MQ4 24$4.3M$3.7MQ1 25$2.8M$7.9MQ2 25$3.5M$3.3MQ3 25$2.0M$6.2MQ4 25$11.0M$1.0MQ1 26$1.7M$3.3MQ2 26
$0$20.0M$40.0MQ4 24Q2 25Q4 25Q2 26

How Often Does Alector Beat Earnings Estimates?

Alector beat EPS estimates in 7 of its last 7 reported quarters, and has beaten 7 quarters in a row.

ALEC quarterly earnings per share and revenue versus Street estimates
Quarter EPS · est. Surprise Revenue · est. Surprise
Q2 2026 $-0.21 est. $-0.23 +8.02% $3.3M est. $1.7M +93.78%
Q1 2026 $-0.21 est. $-0.28 +24.22% $1.0M est. $11.0M −90.52%
Q4 2025 $-0.34 est. $-0.36 +6.41% $6.2M est. $2.0M +218.63%
Q3 2025 $-0.34 est. $-0.41 +17.66% $3.3M est. $3.5M −6.52%
Q2 2025 $-0.30 est. $-0.47 +36.17% $7.9M est. $2.8M +180.73%
Q1 2025 $-0.41 est. $-0.46 +10.87% $3.7M est. $4.3M −13.55%
Q4 2024 $-0.02 est. $-0.54 +96.33% $54.2M est. $20.4M +165.82%

Figures from SEC filings and company reports. Not investment advice.